Cargando…
AMPK promotes induction of the tumor suppressor FLCN through activation of TFEB independently of mTOR
AMPK is a central regulator of energy homeostasis. AMPK not only elicits acute metabolic responses but also promotes metabolic reprogramming and adaptations in the long-term through regulation of specific transcription factors and coactivators. We performed a whole-genome transcriptome profiling in...
Autores principales: | Collodet, Caterina, Foretz, Marc, Deak, Maria, Bultot, Laurent, Metairon, Sylviane, Viollet, Benoit, Lefebvre, Gregory, Raymond, Frederic, Parisi, Alice, Civiletto, Gabriele, Gut, Philipp, Descombes, Patrick, Sakamoto, Kei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Federation of American Societies for Experimental Biology
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6902666/ https://www.ncbi.nlm.nih.gov/pubmed/31404503 http://dx.doi.org/10.1096/fj.201900841R |
Ejemplares similares
-
The tumor suppressor FLCN mediates an alternate mTOR pathway to regulate browning of adipose tissue
por: Wada, Shogo, et al.
Publicado: (2016) -
Flcn-deficient renal cells are tumorigenic and sensitive to mTOR suppression
por: Wu, Mingsong, et al.
Publicado: (2015) -
Benzimidazole derivative small-molecule 991 enhances AMPK activity and glucose uptake induced by AICAR or contraction in skeletal muscle
por: Bultot, Laurent, et al.
Publicado: (2016) -
Phosphoproteomic Analysis of FLCN Inactivation Highlights Differential Kinase Pathways and Regulatory TFEB Phosphoserines
por: Glykofridis, Iris E., et al.
Publicado: (2022) -
Editorial: AMPK and mTOR Beyond Signaling: Emerging Roles in Transcriptional Regulation
por: Audet-Walsh, Étienne, et al.
Publicado: (2021)